| ABCG2 | ATP Binding Cassette Subfamily G Member 2; |
| ALA | aminolevulinic acid; |
| CBF | cerebral blood flow; |
| CTV | Clinical Target Volume; |
| DOTAP | ; 1,2-dioleoyl-3-trimethylammonium-propane; |
| DPPC | 1,2-dipalmitoyl-snglycero-3-phosphocholine; |
| DSPE-mPEG | 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol) |
| EGFR | Epidermal Growth Factor Receptor; |
| FAIR | flow alternating inversion recovery; |
| FDA | Food and Drug Administration; |
| FGR | fluorescence Guided-Resection; |
| GBM | Glioblastoma Multiforme; |
| HBEGF | Heparin-binding EGF-like growth factor; |
| HGG | High-Grade Glioma; |
| LED | Light emitting diode; |
| MRI | Magnetic Resonance Imaging; |
| MTR | MitoTracker Red;. |
| PDT | Photodynamic Therapy; |
| PpIX | Protoporphyrin IX; |
| RARE | rapid acquisition with relaxation enhancement; |
| ROI | Region of Interest |
| SCID | Severe Combined Immunodeficient; |
| TKI | Tyrosine Kinase Inhibitor; |